Jeffrey S. Finnin net worth and biography

Jeffrey Finnin Biography and Net Worth

CFO of Cencora

Jeff Finnin is CoreSite's Chief Financial Officer. Jeff brings more than 25 years of experience to CoreSite and is responsible for the company's accounting and financial activities. Prior to joining CoreSite in 2011, Jeff spent five years with Prologis, where as Managing Director and Chief Accounting Officer, he was responsible for overall corporate policies on accounting and finance. Additionally, Jeff was directly involved with Prologis acquisitions, dispositions and capital market transactions. Jeff has also served as a Partner with KPMG and Arthur Andersen, where he was Industry Lead Partner for the Financial Services and Real Estate practices in Denver. In these roles, he gained extensive experience with SEC regulations, acquisitions, stock mergers, roll-up transactions, divestitures, public offerings and spin-offs. Jeff received his B.S. in Business Administration from Colorado State University.

How do I contact Jeffrey S. Finnin?: The corporate mailing address for Mr. Finnin and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Jeffrey S. Finnin's contact information.
Has Jeffrey S. Finnin been buying or selling shares of Cencora?: Jeffrey S. Finnin has not been actively trading shares of Cencora in the last ninety days. Learn More on Jeffrey S. Finnin's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 15 times. They sold a total of 10,723,964 shares worth more than $2,509,465,836.19. The most recent insider tranaction occured on November, 25th when Chairman Steven H Collis sold 50,000 shares worth more than $12,198,500.00. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 11/25/2024.

Jeffrey S. Finnin Insider Trading History at Cencora

Jeffrey S. Finnin Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $227.69

$225.53

$229.42

50 Day Range

MA: $239.00

$224.81

$251.60

2 Week Range

Now: $227.69

$199.82

$253.27

Volume

1,942,980 shs

Average Volume

1,389,135 shs

Market Capitalization

$44.01 billion

P/E Ratio

30.32

Dividend Yield

0.96%

Beta

0.45

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.